[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Osteopetrosis (Musculoskeletal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Osteopetrosis (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Osteopetrosis (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Osteopetrosis pipeline...

April 2021 30 pages

Otitis Externa (Ear Nose Throat Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Otitis Externa (Ear Nose Throat Disorders) - Drugs in Development, 2021 SUMMARY Otitis Externa (Ear Nose Throat Disorders) - Drugs in Development, 2021 provides an overview of the Otitis Externa pipel...

April 2021 30 pages

Oxysterols Receptor LXR Alpha (Liver X Receptor Alpha or Nuclear Receptor Subfamily 1 Group H Member 3 or LXRA or NR1H3) - Drugs in Development, 2021

 US$ 3,000.00

Oxysterols Receptor LXR Alpha (Liver X Receptor Alpha or Nuclear Receptor Subfamily 1 Group H Member 3 or LXRA or NR1H3) - Drugs in Development, 2021 SUMMARY Oxysterols Receptor LXR Alpha (Liver X Rec...

April 2021 30 pages

Oxytocin Receptor (OTR or OXTR) - Drugs in Development, 2021

 US$ 3,000.00

Oxytocin Receptor (OTR or OXTR) - Drugs in Development, 2021 SUMMARY Oxytocin Receptor (OTR or OXTR) - Drugs in Development, 2021 provides in depth analysis on Oxytocin Receptor (OTR or OXTR) targeted...

April 2021 60 pages

P27 (Negative Regulatory Factor or Nef) - Drugs in Development, 2021

 US$ 3,000.00

P27 (Negative Regulatory Factor or Nef) - Drugs in Development, 2021 SUMMARY P27 (Negative Regulatory Factor or Nef) - Drugs in Development, 2021 provides in depth analysis on P27 (Negative Regulatory...

April 2021 40 pages

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Drugs in Development, 2021

 US$ 3,000.00

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Drugs in Development, 2021 SUMMARY P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Drugs in Development, 2021 provides in depth analysis on P2X Purinoceptor 7...

April 2021 40 pages

p38 MAP Kinase (EC 2.7.11.24) - Drugs in Development, 2021

 US$ 3,000.00

p38 MAP Kinase (EC 2.7.11.24) - Drugs in Development, 2021 SUMMARY p38 MAP Kinase (EC 2.7.11.24) - Drugs in Development, 2021 provides in depth analysis on p38 MAP Kinase (EC 2.7.11.24) targeted pipel...

April 2021 50 pages

Palmitoyl Protein Thioesterase 1 (Palmitoyl Protein Hydrolase 1 or CLN1 or PPT1 or EC 3.1.2.22) - Drugs in Development, 2021

 US$ 3,000.00

Palmitoyl Protein Thioesterase 1 (Palmitoyl Protein Hydrolase 1 or CLN1 or PPT1 or EC 3.1.2.22) - Drugs in Development, 2021 SUMMARY Palmitoyl Protein Thioesterase 1 (Palmitoyl Protein Hydrolase 1 or...

April 2021 30 pages

Pancreatic Diseases (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Pancreatic Diseases (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Pancreatic Diseases (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Pancreatic Diseases pipeline...

April 2021 35 pages

Pancreatic Ductal Adenocarcinoma (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Pancreatic Ductal Adenocarcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Pancreatic Ductal Adenocarcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Pancreatic Ductal...

April 2021 325 pages

Pancreatic Ductal Carcinoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Pancreatic Ductal Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Pancreatic Ductal Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Pancreatic Ductal Carcinoma...

April 2021 30 pages

Pancreatic Endocrine Tumor (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Pancreatic Endocrine Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Pancreatic Endocrine Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Pancreatic Endocrine Tumor pip...

April 2021 30 pages

Pancreatic Islet Transplant Rejection (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Pancreatic Islet Transplant Rejection (Immunology) - Drugs in Development, 2021 SUMMARY Pancreatic Islet Transplant Rejection (Immunology) - Drugs in Development, 2021 provides an overview of the Panc...

April 2021 40 pages

Pandemic Influenza (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Pandemic Influenza (Infectious Disease) - Drugs in Development, 2021 SUMMARY Pandemic Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Pandemic Influenza pipelin...

April 2021 105 pages

Panic Disorders (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Panic Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Panic Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Panic Disorders pipeline...

April 2021 35 pages

Papillary Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Papillary Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Papillary Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Papillary Renal Cell C...

April 2021 35 pages

Papillary Thyroid Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Papillary Thyroid Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Papillary Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Papillary Thyroid Cancer pipeline...

April 2021 70 pages

Papillary Tumor (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Papillary Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Papillary Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Papillary Tumor pipeline landscape. The report provi...

April 2021 30 pages

Paraganglioma (Glomus Jugulare Tumor) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Paraganglioma (Glomus Jugulare Tumor) (Oncology) - Drugs in Development, 2021 SUMMARY Paraganglioma (Glomus Jugulare Tumor) (Oncology) - Drugs in Development, 2021 provides an overview of the Paragang...

April 2021 40 pages

Paralysis (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Paralysis (Central Nervous System) - Drugs in Development, 2021 SUMMARY Paralysis (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Paralysis pipeline landscape. The re...

April 2021 30 pages

Paramyxoviridae Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Paramyxoviridae Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Paramyxoviridae Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Paramyxovi...

April 2021 35 pages

Paranasal Sinus And Nasal Cavity Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Paranasal Sinus And Nasal Cavity Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Paranasal Sinus And Nasal Cavity Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Para...

April 2021 30 pages

Parathyroid Hormone/Parathyroid Hormone Related Peptide Receptor (PTH/PTHrP Type I Receptor or Parathyroid Hormone 1 Receptor or PTH1R) - Drugs in Development, 2021

 US$ 3,000.00

Parathyroid Hormone/Parathyroid Hormone Related Peptide Receptor (PTH/PTHrP Type I Receptor or Parathyroid Hormone 1 Receptor or PTH1R) - Drugs in Development, 2021 SUMMARY Parathyroid Hormone/Parathy...

April 2021 35 pages

Partial Seizure (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Partial Seizure (Central Nervous System) - Drugs in Development, 2021 SUMMARY Partial Seizure (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Partial Seizure pipeline...

April 2021 40 pages

Pediatric Diffuse Intrinsic Pontine Glioma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Pediatric Diffuse Intrinsic Pontine Glioma (Oncology) - Drugs in Development, 2021 SUMMARY Pediatric Diffuse Intrinsic Pontine Glioma (Oncology) - Drugs in Development, 2021 provides an overview of th...

April 2021 95 pages

Pemphigus (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Pemphigus (Immunology) - Drugs in Development, 2021 SUMMARY Pemphigus (Immunology) - Drugs in Development, 2021 provides an overview of the Pemphigus pipeline landscape. The report provides comprehens...

April 2021 30 pages

Penicillin Binding Protein 2 (PBP2) - Drugs in Development, 2021

 US$ 3,000.00

Penicillin Binding Protein 2 (PBP2) - Drugs in Development, 2021 SUMMARY Penicillin Binding Protein 2 (PBP2) - Drugs in Development, 2021 provides in depth analysis on Penicillin Binding Protein 2 (PB...

April 2021 35 pages

Penile Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Penile Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Penile Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Penile Cancer pipeline landscape. The report provides co...

April 2021 70 pages

Peptidyl Prolyl Cis Trans Isomerase (EC 5.2.1.8) - Drugs in Development, 2021

 US$ 3,000.00

Peptidyl Prolyl Cis Trans Isomerase (EC 5.2.1.8) - Drugs in Development, 2021 SUMMARY Peptidyl Prolyl Cis Trans Isomerase (EC 5.2.1.8) - Drugs in Development, 2021 provides in depth analysis on Peptid...

April 2021 30 pages

Periodontal Disease (Mouth and Dental Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Periodontal Disease (Mouth and Dental Disorders) - Drugs in Development, 2021 SUMMARY Periodontal Disease (Mouth and Dental Disorders) - Drugs in Development, 2021 provides an overview of the Periodon...

April 2021 35 pages

Periostin (Osteoblast Specific Factor 2 or POSTN) - Drugs in Development, 2021

 US$ 3,000.00

Periostin (Osteoblast Specific Factor 2 or POSTN) - Drugs in Development, 2021 SUMMARY Periostin (Osteoblast Specific Factor 2 or POSTN) - Drugs in Development, 2021 provides in depth analysis on Peri...

April 2021 35 pages

Peripheral Artery Occlusive Disease (PAOD) (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Peripheral Artery Occlusive Disease (PAOD) (Cardiovascular) - Drugs in Development, 2021 SUMMARY Peripheral Artery Occlusive Disease (PAOD) (Cardiovascular) - Drugs in Development, 2021 provides an ov...

April 2021 30 pages

Peripheral Myelin Protein 22 (Growth Arrest Specific Protein 3 or GAS3 or PMP22) - Drugs in Development, 2021

 US$ 3,000.00

Peripheral Myelin Protein 22 (Growth Arrest Specific Protein 3 or GAS3 or PMP22) - Drugs in Development, 2021 SUMMARY Peripheral Myelin Protein 22 (Growth Arrest Specific Protein 3 or GAS3 or PMP22) -...

April 2021 30 pages

Peripheral Nerve Injury (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Peripheral Nerve Injury (Central Nervous System) - Drugs in Development, 2021 SUMMARY Peripheral Nerve Injury (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Peripher...

April 2021 40 pages

Peripheral Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Peripheral Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Peripheral Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the...

April 2021 50 pages

Peripheral Neuropathy (Sensory Neuropathy) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Peripheral Neuropathy (Sensory Neuropathy) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Peripheral Neuropathy (Sensory Neuropathy) (Central Nervous System) - Drugs in Development, 202...

April 2021 50 pages

Peripheral T-Cell Lymphomas (PTCL) (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Peripheral T-Cell Lymphomas (PTCL) (Oncology) - Drugs in Development, 2021 SUMMARY Peripheral T-Cell Lymphomas (PTCL) (Oncology) - Drugs in Development, 2021 provides an overview of the Peripheral T-C...

April 2021 180 pages

Peroxisome Proliferator Activated Receptor Alpha (Nuclear Receptor Subfamily 1 Group C Member 1 or NR1C1 or PPARA) - Drugs in Development, 2021

 US$ 3,000.00

Peroxisome Proliferator Activated Receptor Alpha (Nuclear Receptor Subfamily 1 Group C Member 1 or NR1C1 or PPARA) - Drugs in Development, 2021 SUMMARY Peroxisome Proliferator Activated Receptor Alpha...

April 2021 60 pages

Peroxisome Proliferator Activated Receptor Gamma (Nuclear Receptor Subfamily 1 Group C Member 3 or NR1C3 or PPARG) - Drugs in Development, 2021

 US$ 3,000.00

Peroxisome Proliferator Activated Receptor Gamma (Nuclear Receptor Subfamily 1 Group C Member 3 or NR1C3 or PPARG) - Drugs in Development, 2021 SUMMARY Peroxisome Proliferator Activated Receptor Gamma...

April 2021 80 pages

Persistent Corneal Epithelial Defects (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Persistent Corneal Epithelial Defects (Ophthalmology) - Drugs in Development, 2021 SUMMARY Persistent Corneal Epithelial Defects (Ophthalmology) - Drugs in Development, 2021 provides an overview of th...

April 2021 35 pages

Pervasive Developmental Disorder (PDD) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Pervasive Developmental Disorder (PDD) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Pervasive Developmental Disorder (PDD) (Central Nervous System) - Drugs in Development, 2021 provid...

April 2021 95 pages

Phosphatidylinositol 3 Kinase (PI3K or EC 2.7.1.137) - Drugs in Development, 2021

 US$ 3,000.00

Phosphatidylinositol 3 Kinase (PI3K or EC 2.7.1.137) - Drugs in Development, 2021 SUMMARY Phosphatidylinositol 3 Kinase (PI3K or EC 2.7.1.137) - Drugs in Development, 2021 provides in depth analysis o...

April 2021 95 pages

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Delta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Delta or PIK3CD or EC 2.7.1.153) - Drugs in Development, 2021

 US$ 3,000.00

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Delta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Delta or PIK3CD or EC 2.7.1.153) - Drugs in Dev...

April 2021 95 pages

Phosphodiesterase 3 (PDE3 or EC 3.1.4.17) - Drugs in Development, 2021

 US$ 3,000.00

Phosphodiesterase 3 (PDE3 or EC 3.1.4.17) - Drugs in Development, 2021 SUMMARY Phosphodiesterase 3 (PDE3 or EC 3.1.4.17) - Drugs in Development, 2021 provides in depth analysis on Phosphodiesterase 3...

April 2021 35 pages

Phosphodiesterase 9 (PDE9 or EC 3.1.4.35) - Drugs in Development, 2021

 US$ 3,000.00

Phosphodiesterase 9 (PDE9 or EC 3.1.4.35) - Drugs in Development, 2021 SUMMARY Phosphodiesterase 9 (PDE9 or EC 3.1.4.35) - Drugs in Development, 2021 provides in depth analysis on Phosphodiesterase 9...

April 2021 30 pages

Phospholipase A2 (PLA2 or Lecithinase A or Phosphatidase or EC 3.1.1.4) - Drugs in Development, 2021

 US$ 3,000.00

Phospholipase A2 (PLA2 or Lecithinase A or Phosphatidase or EC 3.1.1.4) - Drugs in Development, 2021 SUMMARY Phospholipase A2 (PLA2 or Lecithinase A or Phosphatidase or EC 3.1.1.4) - Drugs in Developm...

April 2021 35 pages

Pick Disease (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Pick Disease (Central Nervous System) - Drugs in Development, 2021 SUMMARY Pick Disease (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Pick Disease pipeline landscap...

April 2021 30 pages

Pituitary Tumor (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Pituitary Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Pituitary Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Pituitary Tumor pipeline landscape. The report provi...

April 2021 30 pages

Plaque Psoriasis (Psoriasis Vulgaris) (Immunology) - Drugs in Development, 2021

 US$ 2,500.00

Plaque Psoriasis (Psoriasis Vulgaris) (Immunology) - Drugs in Development, 2021 SUMMARY Plaque Psoriasis (Psoriasis Vulgaris) (Immunology) - Drugs in Development, 2021 provides an overview of the Plaq...

April 2021 210 pages

Plasma Cell Neoplasm (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Plasma Cell Neoplasm (Oncology) - Drugs in Development, 2021 SUMMARY Plasma Cell Neoplasm (Oncology) - Drugs in Development, 2021 provides an overview of the Plasma Cell Neoplasm pipeline landscape. T...

April 2021 30 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1